Notably, bindarit improved cardiac function, reduced fibrosis and increased capillary density after MI, effects associated with reduced ER stress markers (ATF4, CHOP and p-eIF2α) and DNA damage (γH2AX). The gene discussed is ATF4; the disease is myocardial infarction.